NCT06528717 The Role of Maintaining External Carotid Artery Flow in Graft Interposition After Carotid Endarterectomy
| NCT ID | NCT06528717 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute for Cardiovascular Diseases Dedinje |
| Condition | Carotid Artery Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-06-12 |
| Primary Completion | 2024-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2024-06-12 with a primary completion date of 2024-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Analyzing results of carotid graft interposition with and without flow preservation through external carotid artery after endarterectomy.
Eligibility Criteria
Inclusion Criteria: * symptomatic carotid stenosis (\> 50%) * unilateral asymptomatic carotid stenosis (\> 60%) * bilateral asymptomatic carotid stenosis (\> 60%) Exclusion Criteria: * carotid restenosis * "major surgery" in previous 6 months * previous brain trauma or surgery * malignant disease * epilepsy * carotid artery aneurysm
Contact & Investigator
Srdjan Babic, MD PhD
STUDY DIRECTOR
Institute for Cardiovascular Diseases Dedinje
Frequently Asked Questions
Who can join the NCT06528717 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 90 Years, studying Carotid Artery Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06528717 currently recruiting?
Yes, NCT06528717 is actively recruiting participants. Contact the research team at spesic90@gmail.com for enrollment information.
Where is the NCT06528717 trial being conducted?
This trial is being conducted at Belgrade, Serbia.
Who is sponsoring the NCT06528717 clinical trial?
NCT06528717 is sponsored by Institute for Cardiovascular Diseases Dedinje. The principal investigator is Srdjan Babic, MD PhD at Institute for Cardiovascular Diseases Dedinje. The trial plans to enroll 250 participants.